Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients
NCT ID: NCT03947645
Last Updated: 2021-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2019-05-02
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke
NCT06179745
Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke
NCT01644929
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis
NCT00170716
Study to Enhance Motor Acute Recovery With Intensive Training After Stroke
NCT02292251
Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients
NCT01034150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome measure is the Fugl-Meyer Assessment for upper extremity (FM-UE), acquired at baseline, after the intervention period, and at 3 months follow-up. Secondary outcome measures consist of further clinical parameters and biomarkers of corticospinal connectivity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ipsilesional stimulation
Ipsilesional stimulation
Ipsilesional stimulation
Device: ipsilesional transcranial stimulation, neuromuscular Stimulation over target muscle
Contralesional stimulation
Contralesional stimulation
Contralesional stimulation
Device: contralesional transcranial stimulation, neuromuscular stimulation over target muscle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ipsilesional stimulation
Device: ipsilesional transcranial stimulation, neuromuscular Stimulation over target muscle
Contralesional stimulation
Device: contralesional transcranial stimulation, neuromuscular stimulation over target muscle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic stage of stroke (\> 6 months)
* No active finger extension/hand opening of the paretic side
Exclusion Criteria
* Epilepsy
* Metal implants
* Pacemaker
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
In-Tens
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.